% | $
Quotes you view appear here for quick access.

Halozyme Therapeutics, Inc. Message Board

  • moneyandstocks moneyandstocks May 16, 2013 9:56 AM Flag

    PR Newswire: Study Reinforces Hypothesis to Treating Patients w/ Pancreatic Cancer.

    Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society Of Clinical Oncology Annual Meeting
    BY PR Newswire | 05/16/13 - 06:05 PM EDT
    Stock quotes in this article: HALO
    "Data from this single arm Phase 1b study clearly reinforce the hypothesis of treating pancreatic cancer with PEGPH20 in conjunction with chemotherapeutic agents," said Joy Zhu, M.D., Ph.D., Vice President,Oncology Clinical Development, Halozyme. "We look forward to the study investigators presenting the updated study results at the poster session and ensuing discussion

12.09-0.31(-2.50%)Sep 23 4:00 PMEDT